Plexus Corp. (NASDAQ:PLXS) CEO Sells $250,000.00 in Stock

Plexus Corp. (NASDAQ:PLXSGet Free Report) CEO Todd P. Kelsey sold 2,000 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $125.00, for a total value of $250,000.00. Following the completion of the sale, the chief executive officer now owns 85,026 shares in the company, valued at $10,628,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Plexus Stock Performance

Plexus stock opened at $124.09 on Friday. Plexus Corp. has a 12-month low of $87.21 and a 12-month high of $132.46. The stock has a 50-day simple moving average of $113.74 and a 200 day simple moving average of $104.31. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of 34.28 and a beta of 0.90.

Plexus (NASDAQ:PLXSGet Free Report) last announced its earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.17. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The company had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. During the same period in the previous year, the firm posted $1.32 earnings per share. The company’s revenue was down 6.0% on a year-over-year basis. On average, research analysts anticipate that Plexus Corp. will post 3.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Benchmark upped their target price on shares of Plexus from $120.00 to $145.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Needham & Company LLC upped their price objective on shares of Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a research note on Friday, July 26th. Finally, Stifel Nicolaus lifted their target price on shares of Plexus from $90.00 to $95.00 and gave the company a “hold” rating in a research note on Friday, April 26th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $124.00.

Get Our Latest Stock Report on PLXS

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of PLXS. Parallel Advisors LLC raised its position in shares of Plexus by 72.3% during the fourth quarter. Parallel Advisors LLC now owns 348 shares of the technology company’s stock worth $38,000 after acquiring an additional 146 shares during the last quarter. Quest Partners LLC increased its position in Plexus by 36,700.0% in the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after purchasing an additional 367 shares during the period. GAMMA Investing LLC bought a new stake in Plexus during the 4th quarter worth about $44,000. Innealta Capital LLC acquired a new position in Plexus during the 2nd quarter valued at about $51,000. Finally, Cetera Trust Company N.A bought a new position in shares of Plexus in the 4th quarter valued at about $54,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Further Reading

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.